Literature DB >> 16018582

Effects per se of organic solvents in the cerebral acetylcholinesterase of rats.

Adriana D C Obregon1, Maria R C Schetinger, Maísa M Correa, Vera M Morsch, José E P da Silva, Marcos A P Martins, Hélio G Bonacorso, Nilo Zanatta.   

Abstract

Acetylcholinesterase (AChE) was studied in different rat brain regions (cerebellum, hypothalamus, striatum, hippocampus and cortex) in the presence of different organic solvents normally used in the in vitro assay. The organic solvents used were acetone (C3H6O), acetonitrile (C2H3N), ethyl alcohol (C2H6O), isopropyl alcohol (C3H8O), methyl alcohol (CH4O), tert-butyl alcohol (C4H10O) and dimethyl sulfoxide (DMSO, C2H6OS) ranging from 0.6 to 10%. Ethyl and methyl alcohol presented no effect on AChE activity at any of the concentrations and brain structures tested. In the hippocampus, isopropyl alcohol did not demonstrate a significant inhibitory effect, even at high concentrations. Tert-butyl alcohol presented an interesting result, increased AChE activity (P < .05) in the hypothalamus (1.8%), cortex (1.8 and 2.5) and striatum (1.2, 1.8 and 2.5%) and decreased activity at a concentration of 10% in the cortex (P < .05) and striatum (P < .01). Acetone and acetonitrile presented similar results, both significantly inhibiting AChE in all structures (5%, P < .05 and 10%, P < .01). DMSO exhibited a highly inhibitory effect at practically all concentrations tested (P < .01). In conclusion, for testing new compounds on AChE activity in vitro, methyl and ethyl alcohol may be the best organic solvent choice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16018582     DOI: 10.1007/s11064-005-2612-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  22 in total

1.  Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.

Authors:  G Kryger; I Silman; J L Sussman
Journal:  Structure       Date:  1999-03-15       Impact factor: 5.006

2.  Novel and potent tacrine-related hetero- and homobivalent ligands for acetylcholinesterase and butyrylcholinesterase.

Authors:  L Savini; G Campiani; A Gaeta; C Pellerano; C Fattorusso; L Chiasserini; J M Fedorko; A Saxena
Journal:  Bioorg Med Chem Lett       Date:  2001-07-09       Impact factor: 2.823

Review 3.  Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.

Authors:  R J Polinsky
Journal:  Clin Ther       Date:  1998 Jul-Aug       Impact factor: 3.393

4.  High-performance liquid chromatography with on-line coupled UV, mass spectrometric and biochemical detection for identification of acetylcholinesterase inhibitors from natural products.

Authors:  K Ingkaninan; C M de Best; R van der Heijden; A J Hofte; B Karabatak; H Irth; U R Tjaden; J van der Greef; R Verpoorte
Journal:  J Chromatogr A       Date:  2000-03-03       Impact factor: 4.759

5.  Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.

Authors:  A Badia; J E Baños; P Camps; J Contreras; D M Görbig; D Muñoz-Torrero; M Simón; N M Vivas
Journal:  Bioorg Med Chem       Date:  1998-04       Impact factor: 3.641

Review 6.  The polymorphism of acetylcholinesterase: post-translational processing, quaternary associations and localization.

Authors:  J Massoulié; A Anselmet; S Bon; E Krejci; C Legay; N Morel; S Simon
Journal:  Chem Biol Interact       Date:  1999-05-14       Impact factor: 5.192

7.  Profile of acetylcholinesterase in brain areas of male and female rats of adult and old age.

Authors:  A Das; M Dikshit; C Nath
Journal:  Life Sci       Date:  2001-02-16       Impact factor: 5.037

8.  Design, synthesis, and structure-activity relationships of a series of 3-[2-(1-benzylpiperidin-4-yl)ethylamino]pyridazine derivatives as acetylcholinesterase inhibitors.

Authors:  J M Contreras; I Parrot; W Sippl; Y M Rival; C G Wermuth
Journal:  J Med Chem       Date:  2001-08-16       Impact factor: 7.446

9.  Synthesis of dihydroxanthone derivatives and evaluation of their inhibitory activity against acetylcholinesterase: unique structural analogs of tacrine based on the BCD-ring of arisugacin.

Authors:  S J Degen; K L Mueller; H C Shen; J A Mulder; G M Golding; L L Wei; C A Zificsak; A Neeno-Eckwall; R P Hsung
Journal:  Bioorg Med Chem Lett       Date:  1999-04-05       Impact factor: 2.823

10.  Phenylmethylsulfonyl fluoride inhibitory effects on acetylcholinesterase of brain and muscle.

Authors:  K A Skau; M T Shipley
Journal:  Neuropharmacology       Date:  1999-05       Impact factor: 5.250

View more
  3 in total

1.  Acetylcholinesterase activity in rats experimentally demyelinated with ethidium bromide and treated with interferon beta.

Authors:  C M Mazzanti; R M Spanevello; L B Pereira; J F Gonçalves; R Kaizer; M Corrêa; M Ahmed; A Mazzanti; R Festugatto; D L Graça; V M Morsch; M R C Schetinger
Journal:  Neurochem Res       Date:  2006-07-27       Impact factor: 3.996

2.  Acetylcholinesterase Inhibitors Assay Using Colorimetric pH Sensitive Strips and Image Analysis by a Smartphone.

Authors:  Adam Kostelnik; Alexander Cegan; Miroslav Pohanka
Journal:  Int J Anal Chem       Date:  2017-02-13       Impact factor: 1.885

3.  Cholinesterase enzymes inhibitors from the leaves of Rauvolfia reflexa and their molecular docking study.

Authors:  Mehran Fadaeinasab; A Hamid A Hadi; Yalda Kia; Alireza Basiri; Vikneswaran Murugaiyah
Journal:  Molecules       Date:  2013-03-25       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.